secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2024-05-16T23:59:59+00:00
Accession:  0001104659-24-062270
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva Biologics receives conversion notice for 135,431 Series C Preferred shares into ~888K common shares
--------------------------------------------------------------------------------

- Holder converted 135,431 Series C Preferred shares into 888,072 common shares at $1.22 per share.
- Conversion increases outstanding common shares by approximately 888,000, diluting existing shareholders.
- Notice received May 13, 2024; conversion effective upon notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465924062270/0001104659-24-062270-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465924062270/tm2414630d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-062270

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer